CluePoints to Share Case Study on Technology ROI at The SCDM 2022 EMEA Leadership Forum & Conference
Join us at DIA 2022 as we Demystify the De-risking of DCTs
10 Ways the Pandemic Changed CluePoints
10 Ways Mid-Sized BioPharma Has Applied a Pragmatic Approach to RBQM Implementation
Does Central Monitoring Lead to Higher Quality? An Analysis of KRI Outcomes
CluePoints Co-Founder and Chief Executive Officer to Speak at SCOPE Europe
FDA Places Quality Management at the Heart of Updated Inspection Guide
CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.